€39.96
0.73% day before yesterday
Xetra, Sep 06, 05:36 pm CET
ISIN
NL0000240000
Symbol
QIA
Index
DAX
Sector

Qiagen Stock price

€39.96
-1.19 2.88% 1M
-0.87 2.13% 6M
-0.66 1.63% YTD
-1.00 2.45% 1Y
-8.76 17.98% 3Y
+8.10 25.43% 5Y
+20.11 101.30% 10Y
Xetra, Closing price Fri, Sep 06 2024
-0.30 0.73%
ISIN
NL0000240000
Symbol
QIA
Index
DAX
Sector

Key metrics

Market capitalization €8.86b
Enterprise Value €9.34b
P/E (TTM) P/E ratio 139.75
EV/FCF (TTM) EV/FCF 24.22
EV/Sales (TTM) EV/Sales 5.20
P/S ratio (TTM) P/S ratio 4.94
P/B ratio (TTM) P/B ratio 2.79
Revenue growth (TTM) Revenue growth -5.12%
Revenue (TTM) Revenue €1.79b
EBIT (operating result TTM) EBIT €416.11m
Free Cash Flow (TTM) Free Cash Flow €385.70m
Cash position €830.64m
EPS (TTM) EPS €0.29
P/E forward 88.65
P/S forward 4.88
EV/Sales forward 5.14
Show more

Create a Free Account to create an Qiagen alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Qiagen Stock Analysis

Analyst Opinions

20 Analysts have issued a Qiagen forecast:

12x Buy
60%
8x Hold
40%

Analyst Opinions

20 Analysts have issued a Qiagen forecast:

Buy
60%
Hold
40%

Financial data from Qiagen

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
1,795 1,795
5% 5%
100%
- Direct Costs 673 673
4% 4%
38%
1,121 1,121
6% 6%
62%
- Selling and Administrative Expenses 331 331
10% 10%
18%
- Research and Development Expense 180 180
5% 5%
10%
610 610
4% 4%
34%
- Depreciation and Amortization 194 194
3% 3%
11%
EBIT (Operating Income) EBIT 416 416
4% 4%
23%
Net Profit 66 66
79% 79%
4%

In millions EUR.

Don't miss a Thing! We will send you all news about Qiagen directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Head office United States
CEO Thierry Bernard
Employees 5,967
Founded 1996
Website www.qiagen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today